Thermo Fisher Scientific
TMO
2,030 hedge funds and large institutions have $164B invested in Thermo Fisher Scientific in 2020 Q4 according to their latest regulatory filings, with 275 funds opening new positions, 751 increasing their positions, 739 reducing their positions, and 70 closing their positions.
293% more first-time investments, than exits
New positions opened: 275 | Existing positions closed: 70
10% more funds holding
Funds holding: 1,847 → 2,030 (+183)
5% more capital invested
Capital invested by funds: $156B → $164B (+$8.53B)
2% more repeat investments, than reductions
Existing positions increased: 751 | Existing positions reduced: 739
0.99% less ownership
Funds ownership: 89.16% → 88.17% (-0.99%)
7% less funds holding in top 10
Funds holding in top 10: 198 → 184 (-14)
19% less call options, than puts
Call options by funds: $976M | Put options by funds: $1.21B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$322M |
| 2 |
BlackRock
New York
|
+$293M |
| 3 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$249M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$239M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$209M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$770M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$663M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$609M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$355M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$328M |
TMO Hedge Fund Activity: Q4 2020 in Review
2,030 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2020, worth a combined $164B — up 5.5% from $156B a quarter earlier.
Buyers outnumbered sellers: 275 funds opened new TMO positions and 70 closed out — a net gain of 205 holders — while 751 added to existing stakes and 739 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $322M. The largest seller was Capital Research Global Investors, cutting an estimated $770M.
- 2,030 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2020, up from 1,847 in Q3 2020.
- Funds reported $164B of Thermo Fisher Scientific stock for Q4 2020, up 5.5% quarter-over-quarter.
- 275 funds opened new Thermo Fisher Scientific positions in Q4 2020 and 70 closed out, a net change of +205 holders.
- The largest Thermo Fisher Scientific buyer in Q4 2020 was Fidelity Investments, an estimated $322M added.
- The largest Thermo Fisher Scientific seller in Q4 2020 was Capital Research Global Investors, an estimated $770M sold.
Based on aggregated 13F filings for Q4 2020.